发明名称 |
Markers for and methods of targeting tumor stem cells |
摘要 |
The invention provides methods of targeting tumor stem cells that comprise inhibiting the level and/or activity of HDAC1, HDAC7 and phosphorylated HDAC7. The invention further provides methods for identifying tumor stem cells comprising detecting increased levels and/or activity of HDAC1, HDAC7 and phosphorylated HDAC7. Further provided are kits and articles of manufacture comprising inhibitors of the level and/or activity of HDAC1, HDAC7 and phosphorylated HDAC7. Methods for screening for inhibitors of the level and/or activity of HDAC1, HDAC7 and phosphorylated HDAC7 are also provided. |
申请公布号 |
US8912156(B1) |
申请公布日期 |
2014.12.16 |
申请号 |
US201213365073 |
申请日期 |
2012.02.02 |
申请人 |
Whitehead Institute for Biomedical Research |
发明人 |
Ince Tan A.;Lee Tong Ihn;Young Richard A. |
分类号 |
A61K48/00;C07H21/02;C07H21/04 |
主分类号 |
A61K48/00 |
代理机构 |
Morse, Barnes-Brown & Pendleton P.C. |
代理人 |
Warren, Esq. Lisa M.;Fazzolare, Esq. David A.;Morse, Barnes-Brown & Pendleton P.C. |
主权项 |
1. A method for inhibiting the proliferation of or eliminating one or more epithelial carcinoma tumor stem cells that express HDAC1 and/or HDAC7 comprising contacting said one or more cells with an effective amount of at least one inhibitor of HDAC1 and/or an effective amount of at least one inhibitor of HDAC7, wherein an epithelial carcinoma tumor stem cell sample obtained from a source of said one or more cells has been determined to have an increased level or activity of HDAC1 protein and/or an increased level or activity of HDAC7 protein as compared to a standard level. |
地址 |
Cambridge MA US |